Delivery Order SPE2DR25D1106-SPE2DR26FJB0K
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price delivery order has a ceiling value of $10,690.57 and an ultimate completion date of October 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $26,418.80 delivery order to AmerisourceBergen Drug Corp for Zepbound 12.5 mg/0.5 mL pen injections on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injections on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,214.64 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 31, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,063.88 for Zepbound 10 mg/0.5 ml pen injections on December 11, 2025, with completion scheduled for December 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $36,764.00 delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pen injections on October 28, 2025, with completion targeted for October 29, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement with performance at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $6,800.46 delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $18,939.21 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections, with a completion date of January 2, 2026. This is a firm fixed price, non-set-aside contract awarded on December 31, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $13,854.10 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pen injectors, with an ultimate completion date of January 15, 2026. This is a firm fixed-price delivery order with no set-aside designation, executed as a competitive award. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,077.99 by the Defense Logistics Agency (DLA) on December 17, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price contract is classified as a child delivery order and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 18, 2025. The award represents a continuation of AmerisourceBergen's substantial...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJB0KDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,854.88 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on November 24, 2025, with an ultimate completion date of November 25, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. This delivery order for Zepbound—a diabetes medication—falls within the company's demonstrated capability to fulfill federal healthcare requirements across multiple therapeutic domains. The underlying IDC with DLA Troop Support Medical serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 11/23/25 |